ABSTRACT: | Full Text PDF
OBJECTIVE: To compare the effectiveness of Bromocriptine Mesylate (1.25mg) Vs human albumin (50ml) in patients who were at high risk of Ovarian Hyper-stimulation Syndrome (OHSS)
STUDY DESIGN: comparative study.
PLACE AND DURATION OF STUDY: Baqai institute of Reproduction and developmental Sciences (BIRDS) from January 2008 till December 2009.
METHODOLOGY: 60 women who were at high risk of OHSS were selected for prophylaxis of OHSS. 30 women (group 1) were given oral bromocriptine mesylate in a dose of 1.25 mg started from day of ovum pick up at bed time for 7 days and rest 30 women (group 2) received 50 ml human albumin infusion at time of oocyte retrieval and embryo transfer for prophylaxis of OHSS as a standard treatment. Follow up of all these women were done. Any woman who presented with sign/symptoms, suspected of OHSS was hospitalized for further observation and management.
RESULTS: Age range of women was 20
